[CLSTR]
< Back to situations

Monitor this situation.

[SITUATION] · [QUIET] · [BUSINESS]

2 clusters · 2 sources · 7 days · First seen · Last updated

Ocumetics Technology Corp fundraising

Overview

Ocumetics Technology Corp. completed the second tranche of a private placement, issuing 6,250,000 units at $0.40 each. This brought the total proceeds from the offering to $2,948,130, with a potential maximum of $3.2 million. The funds are intended to support the company's first-in-human clinical trials for its dynamic intraocular lens, ongoing research and development, and general working capital.

Entities

Ocumetics Technology Corp. · Bank of America · Ventum Financial Corp. · Noble Capital Markets · Ocugen

Timeline

  1. 19 days ago

    [BUSINESS] 2 sources
    Ocugen and Oculis report quarterly financial results

    Biotech firms Ocugen and Oculis released quarterly results; Ocugen plans Phase 3 trials for OCU410, while Oculis surpassed earnings per share estimates.

  2. 25 days ago

    [BUSINESS] 2 sources
    Ocumetics Technology Corp raises $2.5 million in private placement

    Ocumetics Technology Corp completed a $2.5 million second tranche of its private placement, bringing total proceeds to about $2.95 million to fund first‑in‑human trials of its dynamic intraocular lens.

Sources

channelchek.com · stocknews.com